Smartleaf Asset Management
LFCR icon

Smartleaf Asset Management’s Lifecore Biomedical LFCR Stock Holding History

Smartleaf Asset Management’s Portfolio LFCR Stock Details LFCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.08K Hold
620
– – ﹤0.01% 2843
2026
Q1 		$2.35K Hold
620
– – ﹤0.01% 2915
2025
Q4 		$5.02K Hold
620
– – ﹤0.01% 2694
2025
Q3 		$4.43K Buy
+620
New +$4.69K ﹤0.01% 2409
2025
Q2 		– Sell
-620
Closed -$4.25K – 2872
2025
Q1 		$4.25K Hold
620
– – ﹤0.01% 2247
2024
Q4 		$4.6K Buy
+620
New +$3.96K ﹤0.01% 2277

Other funds holding LFCR

WC
Wynnefield Capital New York $145M AUM 14.57% 1-Year Est. Return
LPAM
Legion Partners Asset Management Los Angeles, California $40.6M AUM 156.55% 1-Year Est. Return
GRIM
Greenhaven Road Investment Management Greenwich, Connecticut $154M AUM 15.9% 1-Year Est. Return
3C
325 Capital New York $419M AUM 75.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Quinn Opportunity Partners
Quinn Opportunity Partners Charlottesville, Virginia $2.16B AUM 28.56% 1-Year Est. Return

Smartleaf Asset Management's LFCR Position: Q2 2026 in Review

Smartleaf Asset Management held its Lifecore Biomedical (LFCR) position steady in Q2 2026 at 620 shares worth $3.08K. The position accounts for ﹤0.01% of the portfolio, ranked #2843.

Smartleaf Asset Management first reported a position in LFCR in Q4 2024 and has held it in 6 quarters since. The position peaked at $5.02K in Q4 2025. 98 funds tracked by Wall St. Rank hold LFCR as of Q2 2026.

  • Smartleaf Asset Management held 620 shares of Lifecore Biomedical worth $3.08K as of Q2 2026.
  • Smartleaf Asset Management left its Lifecore Biomedical share count unchanged in Q2 2026.
  • Lifecore Biomedical made up ﹤0.01% of Smartleaf Asset Management's portfolio in Q2 2026, its #2843 holding.
  • Smartleaf Asset Management first reported a position in Lifecore Biomedical in Q4 2024 and has held it in 6 quarters since.
  • Smartleaf Asset Management's Lifecore Biomedical position peaked at $5.02K in Q4 2025.
  • 98 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q2 2026.

Based on Smartleaf Asset Management's 13F filing for Q2 2026, filed 12 Aug 2026.